Who we are
CHEPLAPHARM Switzerland LLC
CHEPLAPHARM Switzerland LLC, based in Binningen, was founded in 2023 as an affiliate of the globally active CHEPLAPHARM group. The headquarters of the…
Every company is driven by a strong idea.
All of this is only possible with passionate people who go beyond expectations and feel responsible for how and why to do things.
Our leadership team…
Data protection
Applicant data
Medical-scientific enquiries
Applicant data
1. Responsibilities
1.1 Person responsible
The person responsible for processing your personal data is:
…
Data protection
Applicant data
Medical-scientific enquiries
Data Protection
Table of contents
General Responsible body Your rights Processing of personal data during informative use of our…
Drug Safety
Reporting of an event or adverse drug reaction
If you wish to report an adverse reaction, whether or not it is mentioned in the package leaflet, the summary of product characteristics…
9.
Expansion in Oncology: CHEPLAPHARM reaches agreement with Lilly on acquisition of Gemzar®
CHEPLAPHARM Group has entered into a definitive agreement with Eli Lilly and Company to acquire the worldwide rights (except South Korea) for Gemzar® with the active ingredient gemcitabine. The…
